Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15618051rdf:typepubmed:Citationlld:pubmed
pubmed-article:15618051lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:15618051lifeskim:mentionsumls-concept:C1956346lld:lifeskim
pubmed-article:15618051lifeskim:mentionsumls-concept:C2709270lld:lifeskim
pubmed-article:15618051lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:15618051lifeskim:mentionsumls-concept:C0006560lld:lifeskim
pubmed-article:15618051lifeskim:mentionsumls-concept:C0443343lld:lifeskim
pubmed-article:15618051lifeskim:mentionsumls-concept:C0205360lld:lifeskim
pubmed-article:15618051lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:15618051lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:15618051lifeskim:mentionsumls-concept:C1514983lld:lifeskim
pubmed-article:15618051pubmed:issue3lld:pubmed
pubmed-article:15618051pubmed:dateCreated2005-1-21lld:pubmed
pubmed-article:15618051pubmed:abstractTextN-terminal-pro-brain natriuretic peptide (Nt-proBNP) is a reliable risk predictor in acute coronary artery disease (CAD). Little is known about patients with stable angina pectoris (SAP). We aimed to investigate the prognostic impact of Nt-proBNP in a population with CAD especially focussing on patients with SAP.lld:pubmed
pubmed-article:15618051pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15618051pubmed:languageenglld:pubmed
pubmed-article:15618051pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15618051pubmed:citationSubsetIMlld:pubmed
pubmed-article:15618051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15618051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15618051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15618051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15618051pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15618051pubmed:statusMEDLINElld:pubmed
pubmed-article:15618051pubmed:monthFeblld:pubmed
pubmed-article:15618051pubmed:issn0195-668Xlld:pubmed
pubmed-article:15618051pubmed:authorpubmed-author:RupprechtHans...lld:pubmed
pubmed-article:15618051pubmed:authorpubmed-author:BlankenbergSt...lld:pubmed
pubmed-article:15618051pubmed:authorpubmed-author:BickelChristo...lld:pubmed
pubmed-article:15618051pubmed:authorpubmed-author:MeyerJürgenJlld:pubmed
pubmed-article:15618051pubmed:authorpubmed-author:AtheroGene...lld:pubmed
pubmed-article:15618051pubmed:authorpubmed-author:CambienFranço...lld:pubmed
pubmed-article:15618051pubmed:authorpubmed-author:TiretLaurence...lld:pubmed
pubmed-article:15618051pubmed:authorpubmed-author:MünzelThomasTlld:pubmed
pubmed-article:15618051pubmed:authorpubmed-author:LacknerKarl...lld:pubmed
pubmed-article:15618051pubmed:authorpubmed-author:SchnabelRenat...lld:pubmed
pubmed-article:15618051pubmed:authorpubmed-author:LubosEdithElld:pubmed
pubmed-article:15618051pubmed:issnTypePrintlld:pubmed
pubmed-article:15618051pubmed:volume26lld:pubmed
pubmed-article:15618051pubmed:ownerNLMlld:pubmed
pubmed-article:15618051pubmed:authorsCompleteYlld:pubmed
pubmed-article:15618051pubmed:pagination241-9lld:pubmed
pubmed-article:15618051pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:15618051pubmed:meshHeadingpubmed-meshheading:15618051...lld:pubmed
pubmed-article:15618051pubmed:meshHeadingpubmed-meshheading:15618051...lld:pubmed
pubmed-article:15618051pubmed:meshHeadingpubmed-meshheading:15618051...lld:pubmed
pubmed-article:15618051pubmed:meshHeadingpubmed-meshheading:15618051...lld:pubmed
pubmed-article:15618051pubmed:meshHeadingpubmed-meshheading:15618051...lld:pubmed
pubmed-article:15618051pubmed:meshHeadingpubmed-meshheading:15618051...lld:pubmed
pubmed-article:15618051pubmed:meshHeadingpubmed-meshheading:15618051...lld:pubmed
pubmed-article:15618051pubmed:meshHeadingpubmed-meshheading:15618051...lld:pubmed
pubmed-article:15618051pubmed:meshHeadingpubmed-meshheading:15618051...lld:pubmed
pubmed-article:15618051pubmed:meshHeadingpubmed-meshheading:15618051...lld:pubmed
pubmed-article:15618051pubmed:meshHeadingpubmed-meshheading:15618051...lld:pubmed
pubmed-article:15618051pubmed:meshHeadingpubmed-meshheading:15618051...lld:pubmed
pubmed-article:15618051pubmed:meshHeadingpubmed-meshheading:15618051...lld:pubmed
pubmed-article:15618051pubmed:meshHeadingpubmed-meshheading:15618051...lld:pubmed
pubmed-article:15618051pubmed:meshHeadingpubmed-meshheading:15618051...lld:pubmed
pubmed-article:15618051pubmed:meshHeadingpubmed-meshheading:15618051...lld:pubmed
pubmed-article:15618051pubmed:meshHeadingpubmed-meshheading:15618051...lld:pubmed
pubmed-article:15618051pubmed:year2005lld:pubmed
pubmed-article:15618051pubmed:articleTitleAnalysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study.lld:pubmed
pubmed-article:15618051pubmed:affiliationDepartment of Medicine II, Johannes Gutenberg-University Mainz, Langenbeckstr. 1, 55131 Mainz, Germany. schnabelr@web.delld:pubmed
pubmed-article:15618051pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15618051pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15618051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15618051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15618051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15618051lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15618051lld:pubmed